These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 9673807)
1. Consistency of response to sumatriptan nasal spray across patient subgroups and migraine types. Ashford E; Salonen R; Saiers J; Woessner M Cephalalgia; 1998 Jun; 18(5):273-7. PubMed ID: 9673807 [TBL] [Abstract][Full Text] [Related]
2. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies. Ryan R; Elkind A; Baker CC; Mullican W; DeBussey S; Asgharnejad M Neurology; 1997 Nov; 49(5):1225-30. PubMed ID: 9371898 [TBL] [Abstract][Full Text] [Related]
3. Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine. Diamond S; Elkind A; Jackson RT; Ryan R; DeBussey S; Asgharnejad M Arch Fam Med; 1998; 7(3):234-40. PubMed ID: 9596457 [TBL] [Abstract][Full Text] [Related]
4. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study. Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341 [TBL] [Abstract][Full Text] [Related]
5. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569 [TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Winner P; Rothner AD; Saper J; Nett R; Asgharnejad M; Laurenza A; Austin R; Peykamian M Pediatrics; 2000 Nov; 106(5):989-97. PubMed ID: 11061765 [TBL] [Abstract][Full Text] [Related]
8. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients]. Géraud G; Valette C Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800 [TBL] [Abstract][Full Text] [Related]
9. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study. Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326 [TBL] [Abstract][Full Text] [Related]
10. Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine. Natarajan S; Jabbour JT; Webster CJ; Richardson MS Headache; 2004; 44(10):969-77. PubMed ID: 15546259 [TBL] [Abstract][Full Text] [Related]
11. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial. Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494 [TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study). Cady RK; McAllister PJ; Spierings EL; Messina J; Carothers J; Djupesland PG; Mahmoud RA Headache; 2015 Jan; 55(1):88-100. PubMed ID: 25355310 [TBL] [Abstract][Full Text] [Related]
13. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet. Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501 [TBL] [Abstract][Full Text] [Related]
14. How does sumatriptan nasal spray perform in clinical practice? Dahlöf CG; Boes-Hansen S; Cederberg CG; Hardebo JE; Henriksson A Cephalalgia; 1998 Jun; 18(5):278-82. PubMed ID: 9673808 [TBL] [Abstract][Full Text] [Related]
15. Symptomatic treatment of migraine in children: a systematic review of medication trials. Damen L; Bruijn JK; Verhagen AP; Berger MY; Passchier J; Koes BW Pediatrics; 2005 Aug; 116(2):e295-302. PubMed ID: 16061583 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of nasal sumatriptan in 5- to 12-year-old children. Hershey AD; Powers SW; LeCates S; Bentti AL Headache; 2001; 41(7):693-7. PubMed ID: 11554957 [TBL] [Abstract][Full Text] [Related]
17. Parental satisfaction with sumatriptan nasal spray in childhood migraine. Pakalnis A; Kring D; Paolicchi J J Child Neurol; 2003 Nov; 18(11):772-5. PubMed ID: 14696905 [TBL] [Abstract][Full Text] [Related]
18. Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine. Peikert A; Becker WJ; Ashford EA; Dahlof C; Hassani H; Salonen RJ Eur J Neurol; 1999 Jan; 6(1):43-9. PubMed ID: 10209349 [TBL] [Abstract][Full Text] [Related]
19. Clinical applications of new therapeutic deliveries in migraine. Dahlöf C Neurology; 2003 Oct; 61(8 Suppl 4):S31-4. PubMed ID: 14581656 [TBL] [Abstract][Full Text] [Related]
20. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks. Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]